Article Information
vol. 4 no. 2
Published By
Online ISSN
History
- Received September 26, 2017
- Accepted March 9, 2018
- Published online May 4, 2018.
Copyright & Usage
The content of this work is copyright of the authors or their employers. Design and branding are copyright ©ERS 2018 This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
Author Information
- David M.G. Halpin1,
- Ruby Birk2,
- Noushin Brealey2,
- Gerard J. Criner3,
- Mark T. Dransfield4,
- Emma Hilton2,
- David A. Lomas5,
- Chang-Qing Zhu2 and
- David A. Lipson6,7
- 1Dept of Respiratory Medicine, Royal Devon and Exeter Hospital, Exeter, UK
- 2GSK, Uxbridge, UK
- 3Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA
- 4Division of Pulmonary, Allergy and Critical Care Medicine, Lung Health Center, University of Alabama at Birmingham, Birmingham, AL, USA
- 5UCL Respiratory, University College London, London, UK
- 6GSK, King of Prussia, PA, USA
- 7Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
- David M.G. Halpin, Dept of Respiratory Medicine, Royal Devon and Exeter Hospital, Barrack Road, Exeter, EX2 5DW, UK. E-mail: d.halpin{at}nhs.net
Funding
GlaxoSmithKline
CTT116853
Article usage
Altmetrics
Vol 4 Issue 2
Table of Contents
Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses
